UA102081C2 - Universal vaccine for the treatment and prophylaxis of lyme disease for veterinary use and method of its manufacture - Google Patents

Universal vaccine for the treatment and prophylaxis of lyme disease for veterinary use and method of its manufacture

Info

Publication number
UA102081C2
UA102081C2 UAA201007218A UAA201007218A UA102081C2 UA 102081 C2 UA102081 C2 UA 102081C2 UA A201007218 A UAA201007218 A UA A201007218A UA A201007218 A UAA201007218 A UA A201007218A UA 102081 C2 UA102081 C2 UA 102081C2
Authority
UA
Ukraine
Prior art keywords
prophylaxis
treatment
lyme disease
veterinary use
manufacture
Prior art date
Application number
UAA201007218A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Владимир ВРЗАЛ
Либор БИТТНЕР
Иржи НЕПЕРЕНИ
Йосеф ХУМЕЛА
Original Assignee
Байовета, А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байовета, А.С. filed Critical Байовета, А.С.
Publication of UA102081C2 publication Critical patent/UA102081C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a universal vaccine for the treatment and prophylaxis of Lyme disease for veterinary use, based on whole-cell bacterins or bacterial lysates or purificates of at least one or more borrelia genomospecies, which essence lies in the fact that each borrelia genomospecies, selected preferably from the group ofand, contains as a minimum one immunogenic protective protein of outer membrane, either OspA or OspC, or simultaneously both the immunogenic protective proteins OspA and OspC, or possibly other immunogenic protective proteins of outer membrane.
UAA201007218A 2007-11-14 2008-10-21 Universal vaccine for the treatment and prophylaxis of lyme disease for veterinary use and method of its manufacture UA102081C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20070791A CZ301244B6 (en) 2007-11-14 2007-11-14 General-purpose vaccine for treatment and prevention of Lyme borreliosis for human and veterinary use and method for preparing thereof
PCT/CZ2008/000130 WO2009062454A2 (en) 2007-11-14 2008-10-21 Universal vaccine for the treatment and prophylaxis of lyme disease for human and veterinary use and method of its manufacture

Publications (1)

Publication Number Publication Date
UA102081C2 true UA102081C2 (en) 2013-06-10

Family

ID=40600158

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201007218A UA102081C2 (en) 2007-11-14 2008-10-21 Universal vaccine for the treatment and prophylaxis of lyme disease for veterinary use and method of its manufacture

Country Status (5)

Country Link
EP (1) EP2219670A2 (en)
CZ (1) CZ301244B6 (en)
RU (1) RU2472525C2 (en)
UA (1) UA102081C2 (en)
WO (1) WO2009062454A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301244B6 (en) * 2007-11-14 2009-12-16 Bioveta, A.S. General-purpose vaccine for treatment and prevention of Lyme borreliosis for human and veterinary use and method for preparing thereof
CZ301548B6 (en) * 2008-08-20 2010-04-14 Bittner@Libor General-purpose composition for enhancing stamina, prevention, prophylaxis and therapy of Lyme borreliosis for human and veterinary application, process for preparing such composition and its use
PL223175B1 (en) 2012-10-22 2016-10-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Vaccine against Lyme disease, a genetic construct, the recombinant protein, the method for preparing a genetic construct, a method of preparing a vaccine, a method of preparing a recombinant protein, the use of recombinant proteins for the manufacture of a vaccine against Lyme borreliosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2102081C1 (en) * 1991-07-11 1998-01-20 Иммуно АГ Immunogenic composition against laima borreliosis, method to immunize mammals against borreliosis laima, method to obtain protein pc borrelia burgdorferi, diagnostic agent to reveal b burgdorferi and method to reveal antibodies to b burgdorferi
US6872550B1 (en) * 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
DE69408135T2 (en) * 1993-04-29 1998-06-10 Immuno Ag OSPC ANTIGUE VACCINALS IMMUNOGENIC COMPOSITION FOR PREVENTING AND TREATING LYME DISEASE AND RECOMBINANT METHOD FOR PRODUCING SUCH ANTIGENS
US7008625B2 (en) * 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
ES2265643T3 (en) * 1994-04-11 2007-02-16 Wyeth Holdings Corporation BACTERIA OF BORRELIA BURGDORFERI.
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
BRPI0719360B1 (en) * 2006-11-03 2016-09-06 Intervet Int Bv canine lyme disease vaccine, and, use of organisms of a genus of borrelia
CZ301244B6 (en) * 2007-11-14 2009-12-16 Bioveta, A.S. General-purpose vaccine for treatment and prevention of Lyme borreliosis for human and veterinary use and method for preparing thereof

Also Published As

Publication number Publication date
EP2219670A2 (en) 2010-08-25
RU2472525C2 (en) 2013-01-20
WO2009062454A2 (en) 2009-05-22
CZ301244B6 (en) 2009-12-16
CZ2007791A3 (en) 2009-05-27
WO2009062454A3 (en) 2009-07-16
RU2010123897A (en) 2011-12-20

Similar Documents

Publication Publication Date Title
WO2008124647A3 (en) Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
WO2021226436A8 (en) Optimized nucleotide sequences encoding sars-cov-2 antigens
SG160329A1 (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
SG158145A1 (en) Vaccines against chlamydial infection
DE69941454D1 (en) VACCINE AGAINST STAPHYLOKOKEN POISONING
WO2009002947A3 (en) Compounds and peptides that bind the trail receptor
MX2010004482A (en) Anti-rsv g protein antibodies.
EA200870129A1 (en) HUMAN ANTIBODIES AGAINST IL-23, COMPOSITIONS, METHODS AND APPLICATIONS
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
WO2007092496A3 (en) 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
WO2006046017A3 (en) Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter
WO2005009378A3 (en) Polypeptides for inducing a protective immune response against staphylococcus aureus
WO2016115310A3 (en) Device for accommodating surgical tool prior to and during medical procedures
UA102081C2 (en) Universal vaccine for the treatment and prophylaxis of lyme disease for veterinary use and method of its manufacture
MX2015014277A (en) Twin clamp device.
AU2001281145A1 (en) Recombinant constructs of borrelia burgdorferi
WO2009115509A3 (en) Antigenic protein fragments of streptococcus pneumoniae
ATE543511T1 (en) LIVE ATTENUATED VACCINES AGAINST PLEUROPNEUMONIA IN SWINE
Rudakova et al. Penyevskaya NA Genospecies Diversity of Borrelia in Ixodes Ticks of the West Siberia
WO2007098717A3 (en) Chimeric vaccine antigens against classical swine fever virus
EA201491668A1 (en) VACCINES AND METHODS FOR THE TREATMENT OF LIME IN DOGS
WO2013033092A3 (en) Streptococcus suis pilus antigens
WO2008055916A3 (en) New antigens for paratuberculosis diagnosis and vaccination
WO2011009771A3 (en) Immunogenic and therapeutic compositions for streptococcus suis
BRPI1014505A8 (en) MULTIPLE EPITOPE FUSION PROTEIN, METHOD FOR PRODUCING A COMPOSITION, POLYNUCLOTIDE, RECOMBINANT VECTOR, HOST CELL, METHOD FOR PRODUCING A MULTIPLE EPITOPE FUSION PROTEIN, IMMUNODIAGNOSTIC TEST KIT, COMPOSITION AND, USE OF AN EPITOPE FUSION PROTEIN